ArticleBreast cancer research : BCR2021

Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.

Zoltan Szucs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.